Crispr Therapeutics Ag (CRSP)

Total Non-Current Liabilities

$771.32M

Quarterly · Period ending: · USD

CRSP logo

CRSP Total Non-Current Liabilities

Latest reported$771.32M
CRSP Quarterly Total Non-Current Liabilities ($178.39M → $771.32M)
High-resolution chart · PNG

CRSP total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Total Non-Current Liabilities — Quarterly (USD)
Period endingTotal Non-Current Liabilities (USD)
771,323,000
774,978,000
194,310,000
210,369,000
214,224,000
217,495,000
222,172,000
226,661,999
231,081,000
236,091,000
237,976,999
247,802,000
248,149,000
242,674,000
246,470,999
248,531,999
252,575,000
247,562,000
232,534,000
212,596,000
195,801,000
69,322,000
69,473,000
57,568,000
61,357,000
66,117,000
70,221,000
48,932,999
95,150,000
89,665,000
69,075,000
69,311,000
69,495,000
69,722,000
69,003,000
91,244,000
91,358,000
90,256,000
90,118,000
77,523,000
77,119,000
0
178,392,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.